Om

Valbiotis SA is a French biotechnology and health nutrition company focused on the research, development, and distribution of scientifically tested dietary supplements. Valbiotis SA develops products designed to support cardio-metabolic health, including solutions aimed at blood glucose management, blood pressure balance, liver health, immunity, vitality, and general wellbeing. Its portfolio combines plant-based ingredients with a multi-target scientific approach, positioning the company within the growing preventive health and nutrition market. Valbiotis SA serves consumers seeking non-prescription health support and works across wellness-oriented product categories relevant to everyday health challenges. Headquartered in Périgny, France, Valbiotis SA operates as a specialist laboratory with an emphasis on evidence-based nutritional solutions and commercial distribution in selected markets.

Analytikerskøn

Baseret på 1 analytiker

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I VALBIOTIS MED ENDAVU: Køb Valbiotis ($ALVAL) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Valbiotis, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.